The company plans to continue developing different types of plug-ins for customers. Flow cytometry was thrust into the spotlight by the AIDS epidemic in the 1980s as it provides a quick and ...

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...

BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...

23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE ... to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...

Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...

The Flow Core Currently has a BD FacsVantage equipped with 5 lasers and 8 detectors as well as an Accuri Flow Cytometer Analyzer Connected to an Intellicyt Hypercyt robotic system cappable of running ...